Esperion Therapeutics, Inc. (ESPR)

NGM – Real Time Price. Currency in USD

3.18

+3.18 (0.00%)

Market open: Jul 10, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

403M

332M

116M

75M

Cost of goods sold

-129M

-69M

-43M

-27M

Gross Profit

274M

264M

73M

48M

Operating expenses (excl. COGS)

-214M

-209M

-228M

Operating Income

60M

54M

-156M

-180M

Non-operating income, total

-81M

-106M

-54M

Pretax income

-21M

-52M

-209M

-234M

Equity in earnings

Taxes

-2M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-23M

-52M

-209M

-234M

Discontinued operations

Net income

-23M

-52M

-209M

-234M

Dilution adjustment

Preferred dividends

Esperion Therapeutics, Inc. (ESPR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Esperion Therapeutics, Inc. (ESPR)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Esperion Therapeutics, Inc. (ESPR)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Esperion Therapeutics, Inc. (ESPR)

Income Statement (Annual)

Income Statement (Annual)